Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324037 · ClinicalTrials.gov registry record · NA
Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis
A NA study of Suspected Upper Extremity Deep Vein Thrombosis, sponsored by University Medical Center Groningen.
- Completed
- Registry status
- NA
- Development phase
- 406
- Enrollment target
- 18
- Study locations
NCT01324037: Completed NA study of Suspected Upper Extremity Deep Vein Thrombosis, sponsored by University Medical Center Groningen.
NCT01324037 is a NA study of Suspected Upper Extremity Deep Vein Thrombosis that has completed, run by University Medical Center Groningen. The registered enrollment target is 406 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). The trial reports 18 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01324037, a NA study of Suspected Upper Extremity Deep Vein Thrombosis, has completed, sponsored by University Medical Center Groningen.
- COMPLETED
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
- 18
- Study locations
Study Summary
Deep vein thrombosis (DVT) of the arm, officially called upper extremity DVT is a rare disorder and accounts for up to 1-4% of all cases of deep vein thrombosis. In case of a thrombosis, there is a blood clot in one of the veins, which should be treated with blood thinners (anticoagulants). The aim of the present study is to see whether it is safe to use a combination of tests for the diagnosis of arm thrombosis. In all patients, we will use a clinical decision rule (clinical judgement) and a laboratory test (D-dimer testing), in most patients also an ultrasound of the arm will be done. The combination of these tests was found to be safe and effective in patients with thrombosis of the legs.
Conditions Studied
Interventions
- OTHER diagnostic algorithm
Study Locations (18)
Other
- Medical University Graz - Graz
- Medical University Innsbruck - Innsbruck
- University Hospital Leuven - Leuven
- University Hospital Dresden - Dresden
- Ospedali Riuniti - Bergamo
- University Hospital Bologna - Bologna
- Hospital D'Annunziata - Chieti
- University Hospital of Padova - Padua
- Servizio Sanitario Regionale Emilia - Romagna - Reggio Emilia
- Onze Lieve Vrouwe Gasthuis - Amsterdam
- Slotervaart Hospital - Amsterdam
- Maxima Medisch Centrum - Eindhoven/Veldhoven
- University Medical Center Groningen - Groningen
- Academic Hospital Maastricht - Maastricht
- Antonius Hospital - Nieuwegein
- Geneva University Hospital - Geneva
District of Columbia
- Veterans Affairs Hospital - Washington D.C.
Gelderland
- Rijnstate Hospital - Arnhem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01324037 record still lists
NCT01324037 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Suspected Upper Extremity Deep Vein Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which diagnostic algorithm is the first listed.
NCT01324037 lists 18 locations in 3 states (Other, District of Columbia, Gelderland).
Frequently Asked Questions
What is clinical trial NCT01324037 about?
NCT01324037 is a clinical study titled "Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis". Deep vein thrombosis (DVT) of the arm, officially called upper extremity DVT is a rare disorder and accounts for up to 1-4% of all cases of deep vein thrombosis. In case of a thrombosis, there is a blood clot in one of the veins, which should be treated with blood thinners (anticoagulants). The aim ...
What is the current status of trial NCT01324037?
This trial is currently completed. It is a NA study. The enrollment target is 406 participants. The study started on 2010-03. Estimated completion is 2013-04.
What conditions does trial NCT01324037 study?
This clinical trial studies the following conditions: Suspected Upper Extremity Deep Vein Thrombosis.
What interventions are being tested in trial NCT01324037?
The interventions under investigation include: diagnostic algorithm (OTHER).
Who is sponsoring clinical trial NCT01324037?
This trial is sponsored by University Medical Center Groningen, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01324037 being conducted?
This trial has 18 study locations across District of Columbia, Gelderland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01324037's enrollment target sits among peer trials
406 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia